ASHLEY BELL: Open Payments
NPI 1114562782 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,636 in 186 payments from 41 companies in 2025. Trend: 2023 $4,466 · 2024 $4,543 · 2025 $4,636
Food & beverage: $3,677Long term medical supply or device loan: $881Education: $78
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 23 | $1,173 |
| Daiichi Sankyo Inc. | 14 | $345 |
| Incyte Corporation | 12 | $335 |
| Janssen Biotech, Inc. | 11 | $216 |
| Celgene Corporation | 10 | $204 |
| E.R. Squibb & Sons, L.L.C. | 15 | $185 |
| PFIZER INC. | 7 | $159 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $155 |
| AstraZeneca Pharmaceuticals LP | 6 | $147 |
| Astellas Pharma US Inc | 8 | $146 |
Products named: KISQALI, Enhertu, JAKAFI, Nubeqa, Padcev, KEYTRUDA, REBLOZYL, OPDIVO.
Industry payments across TN — which companies pay providers there.
